SARS-CoV-2 and the COVID-19 Pandemic
SARS-CoV-2 and the COVID-19 Pandemic
Warner Greene, MD, PhD, brings his expertise in the field of virology to share insight on SARS-CoV-2 and the COVID-19 pandemic.
Gladstone Experts COVID-19 Greene Lab211 - 225 of 246 Results Clear All
Warner Greene, MD, PhD, brings his expertise in the field of virology to share insight on SARS-CoV-2 and the COVID-19 pandemic.
Gladstone Experts COVID-19 Greene LabKRON4—Gladstone virologist Warner Greene explains that the shelter in place order has helped California control the spread of COVID-19, but warns that individuals must continue to be vigilant and practice social distancing to protect against a resurgence.
Gladstone Experts COVID-19 Virology Greene LabLos Angeles Times—A study in Los Angeles county suggests that the number of COVID-19 cases may be much higher than originally thought, because many people experienced mild symptoms. Gladstone Investigator Warner Greene explains that scientists agree that many cases have been missed, but remain unsure of the true number.
Gladstone Experts COVID-19 Virology Greene LabNikkei Asian Review—Gladstone Senior Investigator Shinya Yamanaka is concerned about the spread of COVID-19 in Japan. To help keep people informed, he has begun a blog to share his scientific insights about the importance of social distancing and to shed light on how scientists are working to fight the virus.
Gladstone Experts COVID-19 Yamanaka LabSan Francisco Chronicle—Senior Investigator Warner Greene describes how quick action to close businesses and send people home helped the Bay Area “crush the curve” of COVID-19.
Gladstone Experts COVID-19 Virology Greene LabJAMA Network—Antibody tests could help identify who has already been infected with SARS-CoV-2, and may now be immune. Gladstone Investigator Melanie Ott explains that understanding how far immunity has spread could help determine when it will be safe to ease social distancing requirements.
Gladstone Experts COVID-19 Virology Ott LabLeading contract research and development organization partners with world-class virology team to fight the COVID-19 pandemic
COVID-19 VirologySTAT News—The Centers for Disease Control and Prevention currently requires that research on SARS-CoV-2, the virus that causes COVID-19, be conducted in special biosafety level 3 labs (BSL-3). Senior Investigator Melanie Ott explains why that requirement could slow down research progress.
Gladstone Experts COVID-19 Ott LabMercury News—San Francisco has the highest per capita COVID-19 testing rate in California. Senior Investigator Warner Greene helps explain why widespread testing is so important to getting the outbreak under control.
Gladstone Experts COVID-19 Virology Greene LabSan Francisco Chronicle—The COVID-19 pandemic has disrupted many industries, including biomedical research. Senior Investigators Warner Greene and Lennart Mucke describe how some labs have shifted the focus of their work to address the current crisis, while others have been forced to put important work on pause.
Research (Publication) COVID-19 Greene Lab Mucke LabWebMD—Scientists urge that testing be completed on drugs, such as chloroquine or hydroxychloroquine, before being used on patients, to prevent possible negative and unintended effects.
Communications COVID-19 Center for HIV Cure Research Virology Greene LabABC7 News—While some COVID-19 cases are severe and cause rapid decline, other patients experience only mild symptoms. Gladstone President Deepak Srivastava explains how stem cell research could help explain this phenomenon, and lead to targeted treatments.
Research (Publication) COVID-19 Stem Cells/iPSCsSTAT News—Gladstone Investigator Melanie Ott describes what’s necessary to set up a biosafety level 3 lab (BSL-3) for research on live coronavirus.
Gladstone Experts Research (Publication) COVID-19 Ott LabNikkei Asian Review—Gladstone Senior Investigator Nevan Krogan describes how his lab launched a collaborative effort to map all human proteins that interact with SARS-CoV-2, the virus that causes COVID-19. Through this heroic effort, a map was produced in just a few weeks. Now, the team is testing to see if drugs can be used to disrupt those interactions to fight the infection.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan LabThe Atlantic—The coronavirus has only 29 proteins. How is it possible that so few amounts can wreak havoc with the tens of thousands of healthy proteins in our bodies?
Communications COVID-19 Virology Ott Lab